Charles River Laboratories International (CRL) Short term Debt (2009 - 2022)

Charles River Laboratories International's Short term Debt history runs 14 years deep, the most recent figure standing at $2.1 million for Q3 2022.

• In Q3 2022, Short term Debt fell 8.62% year-over-year to $2.1 million; the TTM figure through Sep 2022 stood at $2.1 million (down 8.62% YoY), while the FY2021 annual figure was $2.8 million, down 94.43% from the prior year.
• Short term Debt was $2.1 million for Q3 2022 at Charles River Laboratories International, down from $2.4 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $53.7 million in Q2 2020 to a low of $2.1 million in Q3 2022.
• Historically, Short term Debt has averaged $22.4 million across 5 years, with a median of $31.0 million in 2018.
• The sharpest annual moves came in 2019 and 2021: Short term Debt jumped 877.21% in 2019, then plunged 94.43% in 2021.
• A 5-year view of Short term Debt shows it stood at $31.4 million in 2018, then rose by 22.69% to $38.5 million in 2019, then surged by 30.27% to $50.2 million in 2020, then slumped by 94.43% to $2.8 million in 2021, then retreated by 25.62% to $2.1 million in 2022.
• The last three Short term Debt figures came in at $2.1 million (Q3 2022), $2.4 million (Q2 2022), and $2.6 million (Q1 2022), per Business Quant data.